Epsilon M&A Deal Report - Yourgene Health
Transaction Multiples for the Valuation of Private Companies
Novacyt / Yourgene Health
No EMAT :
116303
Announced Date :
03/07/2023
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Novacyt
Target :
Yourgene Health
Country :
United Kingdom
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
Business Description :
Founded in 2013, Yourgene d evelops, manufactures, and commercialises simple and accurate molecular diagnostic and screening solutions, for reproductive health and precision medicine. > Portfolio of...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
ns | ns | ns | ns |
|
|
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 52
| Date | Acquirer | Target | Country | Multiples | See details |
| 08/03/2022 | Sourcebio International | LdPath (now Source LdPath) | United Kingdom | ** | 116280 |
| 26/09/2022 | GENinCode | Abcodia | United Kingdom | ** | 116272 |
Source: Epsilon Research / EMAT
